| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/06/1997 | WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | WO1997008196A1 Neurturin and related growth factors |
| 03/06/1997 | WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | WO1997008184A1 Methods and compositions including dna damaging agents and tyrosine kinase inhibitors or activators |
| 03/06/1997 | WO1997007828A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | WO1997007826A1 In vivo electroporation of cells |
| 03/06/1997 | WO1997007825A1 Circular rna and uses thereof |
| 03/06/1997 | WO1997007824A1 Medicine comprising hgf gene |
| 03/06/1997 | WO1997007817A1 Multi-subtype fiv vaccines |
| 03/06/1997 | WO1997007808A1 Chimeric antiviral agents which incorporate rev binding nucleic acids |
| 03/06/1997 | WO1997007784A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 03/06/1997 | WO1997007667A1 Ribozymes targetting hiv and siv |
| 03/06/1997 | WO1997005255A3 Helper viruses for preparing recombinant viral vectors |
| 03/06/1997 | WO1997005249A3 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | WO1996040929A3 Transferrin receptor genes |
| 03/06/1997 | WO1996036354A3 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 03/06/1997 | DE19532651A1 Viral vector compositions for treating viral infections |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2625279A1 Chromatographic purification of adenovirus and aav |
| 03/06/1997 | CA2230852A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | CA2229749A1 Chimeric antiviral agents which incorporate rev binding nucleic acids |
| 03/06/1997 | CA2229454A1 Circular rna and uses thereof |
| 03/05/1997 | EP0760000A1 Alphavirus expression vector |
| 03/05/1997 | EP0759992A1 Human papilloma virus inhibition by a hairpin ribozyme |
| 03/05/1997 | EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759979A1 Antisense inhibition of hepatitis c virus |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759976A1 The isolation and production of catalytic antibodies using phage technology |
| 03/05/1997 | EP0759938A1 Neurogenic differentiation (neurod) genes and proteins |
| 03/05/1997 | EP0759930A1 Chimeric mhc class i antigens for inducing allograft tolerance |
| 03/05/1997 | EP0759759A1 P75 tnf receptor promoters |
| 03/05/1997 | EP0759695A1 A method of inducing an immune response using vaccinia virus recombinants |
| 02/27/1997 | WO1997007404A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | WO1997007233A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | WO1997007226A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/27/1997 | WO1997007225A2 High efficiency retroviral packaging system |
| 02/27/1997 | WO1997007223A1 Self-deleting vectors for gene therapy |
| 02/27/1997 | WO1997007219A2 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007134A1 Traf inhibitors |
| 02/27/1997 | WO1997007128A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | WO1997007118A1 Enediyne compounds |
| 02/27/1997 | WO1997006833A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006827A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | WO1997006826A1 Gene therapy using ovine adenoviral vectors |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006662A2 Inverted chimeric and hybrid oligonucleotides |
| 02/27/1997 | CA2230195A1 A method to increase the density of antigen on antigen presenting cells |
| 02/27/1997 | CA2229938A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
| 02/27/1997 | CA2229847A1 High efficiency retroviral packaging system |
| 02/27/1997 | CA2229605A1 Genes and proteins controlling cholesterol synthesis |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229287A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors |
| 02/27/1997 | CA2229269A1 Enediyne compounds |
| 02/27/1997 | CA2228965A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | CA2228159A1 Self-deleting vectors for gene therapy |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/27/1997 | CA2226299A1 Hyper comb-branched polymer conjugates |
| 02/27/1997 | CA2202928A1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759082A1 Dna construct for effecting homologous recombination and uses thereof |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759070A1 Blood-borne mesenchymal cells |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0651824A4 Transcription control element for increasing gene expression in myoblasts. |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/25/1997 | US5606047 Includes polynucleotide duplexes that have significant binding activity for lupus antibodies |
| 02/25/1997 | US5606044 Using nucleic acid probes |
| 02/25/1997 | US5606043 Methods for the diagnosis of glaucoma |
| 02/25/1997 | US5605822 Culturing human stem cells in liquid culture medium in the presence of transformed stromal cells |
| 02/20/1997 | WO1997006271A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 02/20/1997 | WO1997006270A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006258A2 cDNA SEQUENCE, AMINO-ACID SEQUENCE, DERIVED FROM THE cDNA SEQUENCE, OF THE PRECURSOR PROTEIN OF HUMAN GCAP-II/UROGUANYLINE, AND AMINO-ACID SEQUENCE OF THE FRAGMENT CIRCULATING IN HUMAN BLOOD |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006253A1 Method of modulating gene expression with reduced immunostimulatory response |
| 02/20/1997 | WO1997006247A2 Deubiquitinating enzymes that regulate cell growth |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997005898A1 Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer |
| 02/20/1997 | WO1996040081A3 Oral delivery of gene constructs |
| 02/20/1997 | DE19530412A1 Selbst deletierende retrovirale Vektoren für die Gentherapie Even deletierende retroviral vectors for gene therapy |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2239616A1 Delivery of an agent to the ductal epithelium in the prophylactic and therapeutic treatment of cancer |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758382A1 Enhancing the sensitivity of tumor cells to therapies |